However, contrasting findings emerged from studies employing fluorescence‐activated cell sorting, indicating that paediatric AML‐derived haematopoietic stem cells (HSCs) and haematopoietic progenitor cells (HPCs) expressed lower levels of RBFOX2 than their cord blood‐derived counterparts.6 The gene discussed is RBFOX2; the disease is acute myeloid leukemia.